Psoriasis is an immuno-mediated condition whose pathogenesis is still unclear
and that in head and neck area presents six specific aspects that justify the
title of this chapter: 1) visibility of the lesions and their impact on quality
of life (QOL); 2) the very common involvement of the scalp; 3) the difficulty of
the treatment; 4) the aberrant epidermalmesenchymal interactions theory; 5) the
rare mucous occurrence and the PPP-tonsil-related disease; 6) the significantly
increased risk of head and neck cancer in men with Psoriasis.
Visibility of head and neck Psoriasis has a considerable impact on patients’
QOL. The differential diagnosis for pustular skin disorders is extensive but
facial Psoriasis more commonly affects eyebrows, the skin between the nose and
the upper lip, the upper forehead and the hairline. Scalp Psoriasis is very
common. Multiple instruments have been used to determine the severity of scalp
Psoriasis and tools for patient self-assessment have also been developed
(Psoriasis Area and Severity Index or PASI, Psoriasis Scalp Severity Index or
PSSI, Body Surface Area or BSA, Physicians' Global Assessment or PGA, Lattice
Physician Global Assessment or LS-PGA, and Self-assessed Psoriasis Area and
Severity Index or SAPASI) but none of the severity scores used for Psoriasis
meets all of the validation criteria required for an ideal score.
Phototherapy (light therapy) for psoriasis on neck
The ultraviolet (UV) light from the sun slows the production of skin cells
and reduces inflammation. Sunlight helps reduce psoriasis symptoms in many
people. If psoriasis is so widespread that topical therapy is impractical, then
artificial light therapy may be used. Proper facilities are required for the two
main forms of light therapy. The medical light source in a physician's office is
not the same as the light sources generally found in tanning salons, which are
of limited use for psoriasis. It must be remembered that all UV radiation has a
potential to cause mutations and skin cancers. Although the incubation period
for these skin cancers is quite long, UV exposures should be carefully
monitored.
UV-B: Ultraviolet B (UV-B) light is used to treat psoriasis. UV-B is light
with wavelengths of 290-320 nanometers (nm). Within the last 10 years, a new
form of UV therapy called narrow-band UV-B (NBUVB) has become available which
seems to be very effective with less burning potential than conventional
broadband UV-B. It presumably contains the most therapeutic wavelengths and
avoids the more toxic ones. (The visible light range is 400 nm-700 nm.) UV-B
therapy is usually combined with one or more topical treatments. UV-B
phototherapy is extremely effective for treating moderate-to-severe plaque
psoriasis. The major drawbacks of this therapy are the time commitment required
for treatments and the accessibility of UV-B equipment.
The Goeckerman regimen uses coal tar followed by UV-B exposure and has been
shown to cause remission in more than 80% of patients. Patients often complain
of the strong odor when coal tar is added, and it stains clothing, towels, and
sheets.
UV-B therapy can be combined with the topical application of corticosteroids,
calcipotriene (Dovonex), tazarotene (Tazorac), or creams or ointments that
soothe and soften the skin.
